Cardiac sarcoid: A clinician's review on how to approach the patient with cardiac sarcoid

Clinical Cardiology

Volumn 35, Issue 7, 2012, Pages 410-415

  Mantini, Nicholas ^a   Williams Jr , Byron ^b   Stewart, Jim ^b   Rubinsztain, Leon ^a   Kacharava, Andro ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PREDNISONE; THALLIUM 201;

ACTION POTENTIAL; ALGORITHM; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIAGNOSTIC VALUE; DRUG EFFICACY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; ELECTROSTIMULATION; FOLLOW UP; GOLD STANDARD; HEART BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART STIMULATION; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; LUNG SARCOIDOSIS; MEDICAL HISTORY; MORTALITY; POSITRON EMISSION TOMOGRAPHY; PROGRAMMED ELECTRICAL STIMULATION; REVIEW; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SIGNAL AVERAGED ELECTROCARDIOGRAM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; SURVIVAL; T WAVE; THORAX RADIOGRAPHY;

EID: 84863439867     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.21982     Document Type: Review

References (43)

1. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med. 1977; 63: 86-108. (Pubitemid 8146656)
2. Silverman K, Hutchins G, Bulkley B., Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978; 58: 1204-1211. (Pubitemid 9092005)
3. Tavora F, Cresswell N, Li L, et al. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol. 2009; 104: 571-577.
4. Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J. 2009; 157: 9-21.
5. Pierre-Louis B, Prasad A, Frishman WH., Cardiac manifestations of sarcoidosis and therapeutic options. Cardiol Rev. 2009; 17: 153-158.
6. Soejima K, Yada H., The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol. 2009; 20: 578-583.
7. Dubrey SW, Falk RH., Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis. 2010; 52: 336-346.
8. Youssef G, Beanlands RS, Birnie DH, et al. Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart. 2011; 97: 2078-2087.
9. Hamzeh NY, Wamboldt FS, Weinberger HD., Management of cardiac sarcoidosis in the United States: a Delphi study. Chest. 2012; 141: 154-162.
10. Yoshida Y, Morimoto S, Hiramitsu S, et al. Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J. 1997; 134: 382-386. (Pubitemid 27431239)
11. Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160: 736-755.
12. Mehta D, Lubitz SA, Frankel Z, et al. Cardiac involvement in patients with sarcoidosis. Chest. 2008; 133: 1426-1435.
13. Burstow DJ, Tajik AJ, Bailey KR, et al. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol. 1989; 63: 478-482. (Pubitemid 19065326)
14. Aydin Kaderli A, Gullulu S, Coskun F, et al. Impaired left ventricular systolic and diastolic functions in patients with early grade pulmonary sarcoidosis. Eur J Echocardiogr. 2010; 11: 809-813.
15. Yodogawa K, Seino Y, Ohara T, et al. Non-invasive detection of latent cardiac conduction abnormalities in patients with pulmonary sarcoidosis: application of signal averaged electrocardiogram. Circ J. 2007; 71: 540-545. (Pubitemid 46513462)
16. Suzuki T, Kanda T, Kubota S, et al. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest. 1994; 106: 1021-1024. (Pubitemid 24309534)
17. Goldner B, Brandspiegel HZ, Horwitz L, et al. Utility of QT dispersion combined with the signal-averaged electrocardiogram in detecting patients susceptible to ventricular tachyarrhythmia. Am J Cardiol. 1995; 76: 1192-1194.
18. Schuller JL, Lowery CM, Zipse M, et al. Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011; 16: 70-76.
19. Matsumoto S, Hirayama Y, Saitoh H, et al. Noninvasive diagnosis of cardiac sarcoidosis using microvolt T-wave alternans. Int Heart J. 2009; 50: 731-739.
20. Cheong BY, Muthupillai R, Nemeth M, et al. The utility of delayed-enhancement magnetic resonance imaging for identifing nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009; 26: 39-46.
21. Ohira H, Tsujino I, Ishimaru S, et al. Myocardial imaging with 18-F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging. 2008; 35: 933-941.
22. Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. Am J Roentgenol. 2005; 185: 110-115.
23. Vignaux O, Dhote R, Duboc D, et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr. 2002; 26: 762-767. (Pubitemid 35423381)
24. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest. 2005; 128: 30-35. (Pubitemid 40994450)
25. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005; 45: 1683-1690. (Pubitemid 40704507)
26. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009; 120: 1969-1977.
27. Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with 13(N)-NH(3)/ (18)F-FDG PET. J Nucl Med. 2003; 44: 1030-1036. (Pubitemid 39663376)
28. Okumura W, Iwasaki T, Toyama T, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med. 2004; 45: 1989-1998. (Pubitemid 47611626)
29. Ishimaru S, Tsujino I, Takei T, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J. 2005; 26: 1538-1543. (Pubitemid 41373496)
30. Langah R, Spicer K, Gebregziabher M, et al., Effectiveness of prolonged fasting 18F-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol. 2009; 16: 801-810.
31. Le Guludec DL, Menad F, Faraggi M, et al. Myocardial sarcoidosis. Chest. 1994; 106: 1675-1682.
32. Eguchi M, Tsuchihashi K, Hotta D, et al. Technetium-99m sestamibi/tetrofosmin myocardial perfusion scanning in cardiac and noncardiac sarcoidosis. Cardiology. 2000; 94: 193-199. (Pubitemid 32250150)
33. Nakazawa A, Ikeda K, Ito Y, et al. Usefulness of dual 67Ga and 99mTc-sestamibi single-photon-emission CT scanning in the diagnosis of cardiac sarcoidosis. Chest. 2004; 126: 1372-1376. (Pubitemid 39391275)
34. Ratner SJ, Fenoglio JJ, Ursell PC., Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest. 1986; 90: 528-533. (Pubitemid 17191564)
35. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999; 138: 299-302. (Pubitemid 29379681)
36. Kandolin R, Lehtonen J, Graner M, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med. 2011; 270: 461-468.
37. Doughan AR, Williams BR., Cardiac sarcoidosis. Heart. 2006; 92: 282-288. (Pubitemid 43131983)
38. Chiu CZ, Nakatani S, Zhang G, et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol. 2005; 95: 143-146. (Pubitemid 40051133)
39. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001; 88: 1006-1010. (Pubitemid 33042612)
40. Yodogawa K, Seino Y, Ohara T, et al. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011; 16: 140-147.
41. Aizer A, Stern EH, Gomes JA, et al. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol. 2005; 96: 276-282. (Pubitemid 40978589)
42. Mehta D, Mori N, Goldbarg SH, et al. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: clinical perspective. Circ Arrhythm Electrophysiol. 2011; 4: 43-48.
43. Zaidi AR, Zaidi A, Vaitkus PT., Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant. 2007; 26: 714-717. (Pubitemid 47001719)